INDIA PHARMA Conference
Context:
Set to take place in New Delhi on April 13-14, 2026, the ninth installment of the INDIA PHARMA summit represents a premier global forum for the pharmaceutical and biotechnology sectors.
The 2026 event highlights a strategic transition in India's industrial approach—moving beyond traditional manufacturing to aggressively promote research, regulatory evolution, and international partnerships.
Background and Evolving Paradigms:
Established in 2016, this initiative serves as a crucial bridge for dialogue between the government and the industry.
It is a joint effort organized by the Department of Pharmaceuticals and the Federation of Indian Chambers of Commerce & Industry (FICCI).
The thematic journey of the conference mirrors the maturation of India's pharma industry.
The inaugural summit centred on self-reliance with the theme "Make in India - Are We on Track?".
In contrast, the 2026 iteration operates under the ambitious banner of "Discover in India: Leapfrogging Life-Sciences Innovation".
Intervening editions have tackled various developmental stages, including a focus on accessibility and accountability through "Responsible Healthcare" in 2017, and a push for future-ready infrastructure with "Driving NextGen Pharmaceuticals" in 2018.
Core Agenda for 2026:
The event agenda includes a flagship CEOs' Roundtable and multiple plenary sessions.
These dialogues are designed to resolve regulatory hurdles, integrate next-generation technologies, and fortify global supply chains.
A critical objective is to harness India’s growing capabilities in the Contract Research, Development and Manufacturing Organization (CRDMO) space.
The conference will also concentrate on accelerating digital transformation, advancing biologics, and establishing a dynamic funding environment for pharmaceutical startups, complete with a dedicated showcase for emerging innovators.